Liran Barda
Hebrew University of Jerusalem
3 Papers
Liran Barda is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Medicine & Engineering. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
CHOP is a critical regulator of acetaminophen-induced hepatotoxicity
Dotan Uzi,Liran Barda,Viviana Scaiewicz,Maya Mills,Tobias Mueller,Águeda González-Rodríguez,Ángela M. Valverde,Takao Iwawaki,Yaacov Nahmias,Ramnik J. Xavier,Raymond T. Chung,Boaz Tirosh,Oren Shibolet +12 more
TL;DR: CHOP upregulation during APAP induced liver injury compromises hepatocyte survival in various mechanisms, in part by curtailing the regeneration phase following liver damage, and plays a pro-damage role in response to APAP intoxication.
178
Flange Fracture and Dislocation: An Unusual Complication of Percutaneous Tracheostomy
TL;DR: These cases suggest that the junction of the flange and the outer cannula may be a weak point and that fracture and dislocation at that site may occur due to excessive or misdirected force and cause loss of airway and a need for orotracheal intubation as performed in these cases.
Journal Article
Neutrophil to Lymphocyte Ratio in Patients Who Received Neoadjuvant Treatment before Gastrectomy.
Yaniv Zager,Yuri Goldes,Dan Assaf,Nadav Zilka,Roi Anteby,Yehonatan Nevo,Liran Barda,Avinoam Nevler +7 more
- 01 May 2023
TL;DR: In this paper , the neutrophil to lymphocyte ratio (NLR) was calculated from preoperative laboratory tests and classified as high (> 4) and low (≤ 4) to evaluate the prognostic value of NLR as an accessory decision-making tool in terms of operating patients after neoadjuvant chemotherapy in patients with resectable gastric cancer.